Now that I'm not getting into starvation mode in the middle of the day, I feel like I have more energy
As much of a miracle weight-loss drug, as the media has made it out to be, it is intended to be used in adjunct to lifestyle interventions to be successful
The recently published randomised controlled Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT) demonstrated that tirzepatide (up to 15 mg) was non-inferior to dulaglutide (1.5 mg) in reducing major adverse cardiovascular events (death from cardiovascular causes, myocardial infarction or stroke) in patients with T2DM and atherosclerotic CVD
Their ages, genders, and BMIs are shown in Fig
Have a conversation with your healthcare provider about weight loss medications, how they work, and their potential risks
If it arrives damaged or you received the wrong item, reach out within 48 hours and we'll get it resolved
